As pandemic threat fades, IHH Healthcare readies for 'springboard year' with new growth strategy

IHH Healthcare is among the companies that have experienced a good run since the start of the Covid-19 pandemic. Now, as infection numbers ease across the world, chief executive officer and managing director Kelvin Loh is expecting a normalisation of the services that the medical services and facilities group provides. Meanwhile, the group is rolling out a new strategy for growth.

Shares of IHH have gained 21.4 per cent in the last 12 months, tracking the company's improvement in profitability as services linked to Covid-19 grew.

The Singapore-listed shares of the counter closed last Friday (Apr 29) at S$2.10. The counter is also listed on Bursa Malaysia, where it closed at RM6.61 - giving it a market capitalisation of RM58.2 billion (S$18.5 billion).